🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

CVS, Nuro to test driverless prescription delivery in Houston area

Published 2020-05-28, 03:10 p/m
© Reuters.
KR
-
UPS
-
CVS
-

By Lisa Baertlein

LOS ANGELES (Reuters) - CVS Health Corp (NYSE:CVS) and unmanned vehicle delivery Nuro in June will start testing a service that drops prescriptions and other essentials free of charge to some customers in the Houston area, the companies said on Thursday.

CVS and other companies are experimenting with myriad ways to serve customers who may be reluctant or unable to visit stores due to the coronavirus pandemic, which has fueled demand for home delivery of everything from groceries and medicine to patio furniture and gardening supplies.

Mountain View, California-based Nuro said in a blog post that the service in Houston will launch with its autonomous Prius fleet and then switch in subsequent months to R2, its low-speed, custom-built delivery bot.

The program will serve customers near a CVS store in Bellaire, Texas. Those customers will need to confirm their identification to gain access to their curbside deliveries, the companies said.

"We want to give our customers more choice in how they can quickly access the medications they need," said Ryan Rumbarger, senior vice president of store operations for CVS Health.

The deal marks the first health-related deal for Nuro, which has tested grocery delivery with supermarket giant Kroger (NYSE:KR) Co in Houston.

CVS also is testing drone deliveries with United Parcel Service Inc (NYSE:UPS)'s Flight Forward division.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.